SCHEMBL1031135

SCHEMBL1031135

CC(=O)Nc1nc2cc(Br)ccc2c(=O)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
DYRK1A Q13627 3/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
POLB P06746 2/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
GDA Q9Y2T3 1/20 0.44
ESR1 P03372 1/20 0.44
PTGES O14684 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 1/20 0.43
FGFR1 P11362 1/20 0.42
FGFR2 P21802 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2919354 0.81 LMNA (0.63) LMNADYRK1AMEN1KMT2ASMN1; SMN2
SCHEMBL21403473 0.80 KDM4E (0.56) LMNADYRK1AMEN1KMT2ASMN1; SMN2
SCHEMBL2955695 0.78 LMNA (0.63) LMNADYRK1AMEN1KMT2ASMN1; SMN2
SCHEMBL3226572 0.77 TYMS (0.63) LMNASMN1; SMN2POLBRAB9ANPC1
SCHEMBL29440611 0.77 TYMS (0.63) LMNASMN1; SMN2POLBRAB9ANPC1
SCHEMBL21089735 0.76 PTGES (0.41) MEN1KMT2ASMN1; SMN2RAB9APTGES
SCHEMBL12509441 0.76 FGFR1 (0.53) LMNADYRK1AMEN1KMT2ASMN1; SMN2
SCHEMBL12509440 0.76 ALDH1A1 (0.49) LMNAMEN1KMT2ASMN1; SMN2POLB
SCHEMBL31153423 0.74 KDM4E (0.46) MEN1KMT2ARAB9ANPC1PTGES
SCHEMBL13343607 0.74 KDM4E (0.46) MEN1KMT2ARAB9ANPC1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086585-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed
EP-2270002-A1 Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg (NL) 2011-01-05 EP disclosed